Divi’s Laboratories Ltd. (DIVISLAB): Divi’s Laboratories 52 Week High Streak: Second Straight Session Nears Fresh Peak
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
Divi’s Laboratories Ltd. has now set a fresh 52-week high for its second straight session, with the streak carrying a cumulative gain of 2.74% and the latest peak at Rs 9,613.25. The stock last traded at Rs 9,560.15, and the latest Univest data confirms the repeated-high pattern but does not establish a company-specific catalyst for the continued move.
As of 09 September 2026 at 9:22 AM IST, the share price was below the previous close of Rs 9,570.55 after opening at Rs 9,596.65 and moving between Rs 9,541.05 and Rs 9,613.25. Turnover stood at Rs 2.11 crore and market capitalisation at Rs 2,47,018.51 crore. For readers, the repetition matters more than a one-day breakout because it shows the stock has kept revisiting new one-year highs across sessions.
Divi’s Laboratories 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 9,560.15 |
| Previous Close | Rs 9,570.55 |
| Today's Move | Rs -10.4 (-0.11%) |
| Open | Rs 9,596.65 |
| High | Rs 9,613.25 |
| Low | Rs 9,541.05 |
| Turnover | Rs 2.11 crore |
| Market Capitalisation | Rs 2,47,018.51 crore |
Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 9,560.15 versus the previous close of Rs 9,570.55, a fall of 0.11%. The stock opened at Rs 9,596.65, reached a high of Rs 9,613.25 and touched a low of Rs 9,541.05.
Divi’s Laboratories share price today was slightly lower than the previous close, even though the stock had already printed a fresh one-year high earlier in the morning. The latest trade at Rs 9,560.15 compared with the previous close of Rs 9,570.55 shows a day change of Rs -10.40, or -0.11%. The move matters because the repeated-high streak is being tracked alongside a modest intraday pullback, not alongside a strong gap-up session.
The stock opened at Rs 9,596.65, touched a high of Rs 9,613.25 and a low of Rs 9,541.05. That high matches the 52-week peak, so the streak remains intact even though the last traded price was slightly below it. Turnover of Rs 2.11 crore gives a factual read on traded value during the session, while market capitalisation of Rs 2,47,018.51 crore keeps Divi’s Laboratories among the larger names in the healthcare space. For anyone tracking Divi’s Laboratories stock news, the key point is that the market has continued to mark up the stock across consecutive sessions.
What the Repeated 52-Week Highs Show
Divi’s Laboratories 52 Week High Streak now covers a second straight session, and that sequence is the main story rather than the day’s small price change. The stock has moved 2.74% across the streak, which is the cleanest measure of how far the latest run has travelled since the first breakout. The current 52-week high of Rs 9,613.25 is the same level reached in the latest session, so the current peak is not a fresh all-time high claim unless an all-time high is separately established.
For readers searching for Divi’s Laboratories Back To Back 52 Week Highs or Divi’s Laboratories New One Year High, the pattern confirms continuation across sessions, but it still does not explain why the move has persisted. The data shows price behaviour, not a named corporate trigger. That distinction matters because a repeated high pattern can stay in place even when the price pauses below the peak during intraday trade. In other words, the streak is the fact; the reason is not confirmed here.
Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,47,018.51 crore |
| P/E Ratio | 86.86x |
| P/B Ratio | 14.38x |
| ROE | 16.19% |
| ROCE | 21.51% |
| EPS | Rs 110.18 |
| Book Value Per Share | Rs 665.36 |
| Dividend Yield | 0.31% |
Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 86.86x, P/B 14.38x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.
Divi’s Laboratories Ltd. has a market capitalisation of Rs 247018.51 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 86.86x, P/B at 14.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.31%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.08x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 86.86x |
| Benchmark Median P/E | 32.08x |
| Benchmark Average P/E | 48.91x |
| Benchmark P/E Range | 3.39x to 668.68x |
| Company P/B Ratio | 14.38x |
| Benchmark Median P/B | 3x |
| Company ROE | 16.19% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 21.51% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 2,47,018.51 crore |
| Benchmark Median Market Cap | Rs 704.3 crore |
Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 86.86x, which is above the benchmark median of 32.08x, a difference of +170.76%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.81%, a difference of +37.09%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.68%, a difference of +57.24%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,86,874.73 | 86.55 | 21.03 | 26.76 | 19.27 |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,825.66 | 37.31 | 5.22 | 14.85 | 19.11 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,211.69 | 25.42 | 4.25 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,773 | 33.17 | 3.18 | 11.83 | 16 |
| Laurus Labs Ltd. | LAURUSLABS | 1,00,943.83 | 96.14 | 18.64 | 18.31 | 18.2 |
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 86.86x compared with the displayed peer median of 37.31x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,47,018.51 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Divi’s Laboratories
- Divi’s Laboratories 52 Week High Streak has continued for a second straight session.
- The cumulative move across the streak is 2.74%.
- The latest 52-week high stands at Rs 9,613.25.
- P/E of 86.86 and P/B of 14.38 keep valuation central to Divi’s Laboratories stock analysis.
- ROE of 16.19% and ROCE of 21.51% provide a useful fundamental backdrop.
About Divi’s Laboratories
Divi’s Laboratories Ltd. is part of the Pharmaceuticals & Drugs industry in the Healthcare sector. The company has a market capitalisation of Rs 2,47,018.51 crore and remains one of the more closely tracked names among healthcare investors following the latest 52 Week High Stocks theme. For readers comparing Divi’s Laboratories market cap, valuation and stock performance, the company sits in the upper tier of the domestic pharma universe.
The business is followed for its financial ratios, including EPS, book value, ROE and ROCE, along with its price performance on the NSE and BSE. Divi’s Laboratories share price update queries often focus on whether the stock can keep trading near a fresh yearly high while valuation stays elevated relative to the broader industry.
Track Divi’s Laboratories on Univest
Track Divi’s Laboratories on Univest for a live view of the share price, stock news, market cap, financial ratios and company updates. The stock page also helps readers compare the latest move with other 52 Week High Stocks and follow the next change in Divi’s Laboratories share price today.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What does Divi's Laboratories 52 Week High Streak mean?
Ans. It means Divi's Laboratories has set a fresh 52-week high for two straight sessions. The current streak shows repeated price discovery near a one-year peak, which is different from a one-day breakout headline.
How many sessions has Divi's Laboratories stayed at a fresh 52-week high?
Ans. The stock has done so for a second straight session. That is the exact streak length provided by the latest Univest figures, and it is the main reason this article focuses on the repeated-high pattern.
What is the cumulative move across the Divi's Laboratories streak?
Ans. Divi's Laboratories has moved 2.74% across the streak. That cumulative figure helps readers judge the full move across consecutive sessions instead of looking only at the latest trade or the latest intraday high.
What is the current 52-week high for Divi's Laboratories?
Ans. The latest 52-week high is Rs 9,613.25. The stock touched that level in the current session, which keeps the streak active even though the last traded price was slightly below the peak.
Is Divi's Laboratories trading above the previous close?
Ans. No. The last traded price of Rs 9,560.15 was below the previous close of Rs 9,570.55. The day change was Rs -10.40, or -0.11%, as of 09 September 2026 at 9:22 AM IST.
What does Divi's Laboratories valuation look like?
Ans. Divi's Laboratories trades at a P/E of 86.86 and a P/B of 14.38. Those multiples are well above the sector medians in the latest Univest data, so valuation is an important part of any Divi's Laboratories stock analysis.
How does Divi's Laboratories compare with pharma peers?
Ans. Compared with selected peers, Divi's Laboratories has a richer valuation than most names in the set, though its ROE and ROCE remain solid. That mix of premium pricing and healthy returns is central to peer comparison.
What should investors watch next in Divi's Laboratories?
Ans. Investors can track whether the stock continues to print fresh highs, how the share price behaves around Rs 9,613.25, and whether valuation stays supported by returns and business performance. The repeated-high pattern is clear; the next catalyst is not confirmed here.
Track Divi's Laboratories Ltd. (DIVISLAB) Share Price on Univest
Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
